Rokiprim®

solution for infusion

250 ml contain
800 mg Sulfametrole and
160 mg Trimethoprim

Properties

  • Broad antimicrobial spectrum1
  • Excellent tissue penetrationt2
  • Good efficacy against multiresistant bacteria and opportunistic microbes in immunocompromised patients (Pneumocystis jirovecii, Stenotrophomonas maltophilia, Burkholderia spp)

Indications

  • Urinary tract and renal infections
  • Gastrointestinal infections: typhus, paratyphus A and B, diarrhoea (only if caused by enterotoxigenic Escherichia coli)
  • Treatment of choice (both, primary and secondary) of pneumonia caused by pneumocystis jirovecii (carinii)
  • Alternative treatment option for otorhinolaryngologic infections and respiratory tract infections: acute exacerbation of chronic bronchitis, otitis media
  • Alternative treatment option for infection of the female and male genital organs including gonorrhoea
  • Alternative treatment option for skin infections (with multiresistant staphylococci)
1 Vouloumanou E et al. International Journal of Antimicrobial Agents 2011; 38: 197–216

2 Livermore DM et al. J. Antimicrob. Chemother. 2014;

Use

Adults:

  • Standard dosage: 2 x 250 ml daily (at intervals of 12 hours)
  • Intensive therapy for severe infections: 3 x 250 ml daily (at intervals of 8 hours

Package insert

lidaprim_rokiprim_en.pdf